Citadel Advisors’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-26,469
Closed -$1.12M 15757
2024
Q1
$1.12M Buy
26,469
+11,393
+76% +$480K ﹤0.01% 6696
2023
Q4
$630K Sell
15,076
-7,590
-33% -$280K ﹤0.01% 7612
2023
Q3
$855K Buy
+22,666
New +$851K ﹤0.01% 6903
2022
Q4
Sell
-11,425
Closed -$343K 15619
2022
Q3
$343K Sell
11,425
-6,622
-37% -$228K ﹤0.01% 9277
2022
Q2
$653K Buy
18,047
+4,458
+33% +$170K ﹤0.01% 8053
2022
Q1
$587K Sell
13,589
-4,666
-26% -$218K ﹤0.01% 9010
2021
Q4
$915K Buy
18,255
+12,250
+204% +$686K ﹤0.01% 8171
2021
Q3
$382K Buy
+6,005
New +$416K ﹤0.01% 10526
2021
Q1
Sell
-22,378
Closed -$1.64M 13851
2020
Q4
$1.64M Sell
22,378
-27,520
-55% -$1.77M ﹤0.01% 5788
2020
Q3
$2.74M Sell
49,898
-38,761
-44% -$2.41M ﹤0.01% 4134
2020
Q2
$5.89M Sell
88,659
-104,204
-54% -$6.99M ﹤0.01% 2866
2020
Q1
$11.8M Buy
192,863
+135,018
+233% +$10M 0.01% 1695
2019
Q4
$5.09M Sell
57,845
-15,321
-21% -$1.29M ﹤0.01% 3055
2019
Q3
$5.52M Buy
73,166
+27,733
+61% +$2.25M ﹤0.01% 2973
2019
Q2
$3.88M Buy
45,433
+3,958
+10% +$391K ﹤0.01% 3461
2019
Q1
$4.48M Sell
41,475
-40,541
-49% -$4.04M ﹤0.01% 3160
2018
Q4
$6.94M Buy
82,016
+37,088
+83% +$3.58M ﹤0.01% 2343
2018
Q3
$4.42M Buy
+44,928
New +$4.86M ﹤0.01% 3162
2018
Q2
Sell
-5,968
Closed -$589K 9402
2018
Q1
$589K Buy
+5,968
New +$605K ﹤0.01% 5619
2017
Q3
Sell
-5,617
Closed -$629K 8174
2017
Q2
$629K Buy
+5,617
New +$635K ﹤0.01% 4791
2017
Q1
Sell
-8,050
Closed -$847K 8169
2016
Q4
$847K Buy
+8,050
New +$843K ﹤0.01% 4084
2016
Q2
Sell
-4,044
Closed -$579K 7538
2016
Q1
$579K Buy
+4,044
New +$574K ﹤0.01% 4201
2015
Q2
Sell
-10,308
Closed -$1.45M 9170
2015
Q1
$1.45M Buy
+10,308
New +$1.59M ﹤0.01% 3475
2014
Q4
Sell
-5,449
Closed -$839K 8790
2014
Q3
$839K Buy
+5,449
New +$820K ﹤0.01% 3932
2014
Q2
Sell
-4,642
Closed -$515K 8384
2014
Q1
$515K Buy
+4,642
New +$505K ﹤0.01% 4308

Other funds holding TARO